1178 related articles for article (PubMed ID: 34506535)
41. Risk of thromboembolism in patients with COVID-19 who are using hormonal contraception.
Cohen MA; Edelman A; Paynter R; Henderson JT
Cochrane Database Syst Rev; 2023 Jan; 1(1):CD014908. PubMed ID: 36622724
[TBL] [Abstract][Full Text] [Related]
42. Effect of menopausal hormone therapy on COVID-19 severe outcomes in women - A population-based study of the US National COVID Cohort Collaborative (N3C) data.
Yoshida Y; Chu S; Zu Y; Fox S; Mauvais-Jarvis F;
Maturitas; 2023 Apr; 170():39-41. PubMed ID: 36773498
[TBL] [Abstract][Full Text] [Related]
43. Hormone replacement therapy and risk for coronary heart disease. Data from the CORA-study--a case-control study on women with incident coronary heart disease.
Windler E; Zyriax BC; Eidenmüller B; Boeing H
Maturitas; 2007 Jul; 57(3):239-46. PubMed ID: 17292571
[TBL] [Abstract][Full Text] [Related]
44. Hormone replacement therapy did not increase risk of melanoma in Chinese female with menopausal and postmenopausal disorders: A population-based retrospective cohort study in Taiwan.
Ma J; Chen YH; Chiang CP; Wang WM; Chung CH; Tsao CH; Weng ZX; Hung CT; Chien WC
J Dermatol; 2023 Sep; 50(9):1162-1169. PubMed ID: 37365983
[TBL] [Abstract][Full Text] [Related]
45. Important factors for use of hormone replacement therapy: a population-based study of Swedish women. The Women's Health in Lund Area (WHILA) Study.
Li C; Samsioe G; Lidfelt J; Nerbrand C; Agardh CD;
Menopause; 2000; 7(4):273-81. PubMed ID: 10914621
[TBL] [Abstract][Full Text] [Related]
46. The effect of hormone replacement therapy of the age-related rise of factor VIIc, and its activity state.
Wright D; Poller L; Thomson JM; Burrows GE; Hirst CF; Sidebotham A
Thromb Res; 1997 Mar; 85(6):455-64. PubMed ID: 9101638
[TBL] [Abstract][Full Text] [Related]
47. Estrogen-modulating treatment among mid-life women and COVID-19 morbidity and mortality: a multiregister nationwide matched cohort study in Sweden.
Elenis E; Kallner HK; Karalexi MA; Hägg D; Linder M; Fall K; Papadopoulos FC; Skalkidou A
BMC Med; 2024 Feb; 22(1):84. PubMed ID: 38414048
[TBL] [Abstract][Full Text] [Related]
48. Incidence of benign and malignant breast disorders in women taking hormones (contraceptive pill or hormonal replacement therapy).
Tzingounis V; Cardamakis E; Ginopoulos P; Argiropoulos G
Anticancer Res; 1996; 16(6C):3997-4000. PubMed ID: 9042326
[TBL] [Abstract][Full Text] [Related]
49. Does estrogen deprivation affect pelvic floor muscle contractility?
Dietz HP; Socha M; Atan IK; Subramaniam N
Int Urogynecol J; 2020 Jan; 31(1):191-196. PubMed ID: 31055611
[TBL] [Abstract][Full Text] [Related]
50. Hormone replacement therapy and the breast.
Dixon JM
Surg Oncol; 2003 Dec; 12(4):251-63. PubMed ID: 14998565
[TBL] [Abstract][Full Text] [Related]
51. Exercise for vasomotor menopausal symptoms.
Daley A; MacArthur C; Mutrie N; Stokes-Lampard H
Cochrane Database Syst Rev; 2007 Oct; (4):CD006108. PubMed ID: 17943886
[TBL] [Abstract][Full Text] [Related]
52. Relation of hormone and menopausal status to outcomes following excimer laser photorefractive keratectomy in women. Melbourne Excimer Laser Group.
McCarty CA; Ng I; Waldron B; Garrett SK; Downie JA; Aldred GF; Wolfe RJ; Taylor HR
Aust N Z J Ophthalmol; 1996 Aug; 24(3):215-22. PubMed ID: 8913123
[TBL] [Abstract][Full Text] [Related]
53. Hormone replacement therapy and asthma onset in menopausal women: National cohort study.
Shah SA; Tibble H; Pillinger R; McLean S; Ryan D; Critchley H; Price D; Hawrylowicz CM; Simpson CR; Soyiri IN; Appiagyei F; Sheikh A; Nwaru BI
J Allergy Clin Immunol; 2021 May; 147(5):1662-1670. PubMed ID: 33279576
[TBL] [Abstract][Full Text] [Related]
54. Hormone replacement therapy for women previously treated for endometrial cancer.
Edey KA; Rundle S; Hickey M
Cochrane Database Syst Rev; 2018 May; 5(5):CD008830. PubMed ID: 29763969
[TBL] [Abstract][Full Text] [Related]
55. Combined estrogen and progestin hormone replacement therapy in relation to risk of breast cancer in middle-aged women.
Stanford JL; Weiss NS; Voigt LF; Daling JR; Habel LA; Rossing MA
JAMA; 1995 Jul; 274(2):137-42. PubMed ID: 7596001
[TBL] [Abstract][Full Text] [Related]
56. The relevance of the Women's Health Initiative results on combined hormone replacement therapy in clinical practice.
Lemay A
J Obstet Gynaecol Can; 2002 Sep; 24(9):711-5. PubMed ID: 12360366
[TBL] [Abstract][Full Text] [Related]
57. Exogenous Estrogen in the Development of Head and Neck Cancer.
Doll C; Hofmann E; Preissner R; Heiland M; Seeland U; Konietschke F; Sehouli J; Preissner S
JAMA Otolaryngol Head Neck Surg; 2024 May; 150(5):378-384. PubMed ID: 38546631
[TBL] [Abstract][Full Text] [Related]
58. Lipids and cardiovascular disease: do the findings and therapy apply equally to men and women?
LaRosa JC
Womens Health Issues; 1992; 2(2):102-11; discussion 111-3. PubMed ID: 1617306
[TBL] [Abstract][Full Text] [Related]
59. Estrogens and the risk of complex regional pain syndrome (CRPS).
de Mos M; Huygen FJ; Stricker BH; Dieleman JP; Sturkenboom MC
Pharmacoepidemiol Drug Saf; 2009 Jan; 18(1):44-52. PubMed ID: 19111016
[TBL] [Abstract][Full Text] [Related]
60. Could sex-specific subtypes of hand osteoarthritis exist? A retrospective study in women presenting to secondary care.
Gulati M; Brewer G; Judge A; Kennedy D; Vincent TL; Watt FE
Front Pain Res (Lausanne); 2024; 5():1331187. PubMed ID: 38410176
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
